nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexobarbital—CYP1A2—chronic obstructive pulmonary disease	0.414	1	CbGaD
Hexobarbital—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0692	0.147	CbGbCtD
Hexobarbital—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.06	0.127	CbGbCtD
Hexobarbital—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0442	0.0936	CbGbCtD
Hexobarbital—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0442	0.0936	CbGbCtD
Hexobarbital—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0367	0.0778	CbGbCtD
Hexobarbital—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0367	0.0778	CbGbCtD
Hexobarbital—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0347	0.0734	CbGbCtD
Hexobarbital—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0282	0.0597	CbGbCtD
Hexobarbital—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0278	0.059	CbGbCtD
Hexobarbital—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.019	0.0403	CbGbCtD
Hexobarbital—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0186	0.0393	CbGbCtD
Hexobarbital—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0182	0.0385	CbGbCtD
Hexobarbital—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0162	0.0343	CbGbCtD
Hexobarbital—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0095	0.0201	CbGbCtD
Hexobarbital—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00897	0.019	CbGbCtD
Hexobarbital—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000154	0.00135	CbGpPWpGaD
Hexobarbital—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000152	0.00134	CbGpPWpGaD
Hexobarbital—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000152	0.00133	CbGpPWpGaD
Hexobarbital—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000152	0.00133	CbGpPWpGaD
Hexobarbital—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.00133	CbGpPWpGaD
Hexobarbital—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00015	0.00131	CbGpPWpGaD
Hexobarbital—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00015	0.00131	CbGpPWpGaD
Hexobarbital—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00015	0.00131	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000148	0.0013	CbGpPWpGaD
Hexobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000148	0.0013	CbGpPWpGaD
Hexobarbital—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000147	0.00129	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000147	0.00129	CbGpPWpGaD
Hexobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000146	0.00128	CbGpPWpGaD
Hexobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.00014	0.00123	CbGpPWpGaD
Hexobarbital—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.00014	0.00122	CbGpPWpGaD
Hexobarbital—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000138	0.00121	CbGpPWpGaD
Hexobarbital—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.00121	CbGpPWpGaD
Hexobarbital—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.00118	CbGpPWpGaD
Hexobarbital—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.00117	CbGpPWpGaD
Hexobarbital—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000133	0.00117	CbGpPWpGaD
Hexobarbital—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000132	0.00115	CbGpPWpGaD
Hexobarbital—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000125	0.0011	CbGpPWpGaD
Hexobarbital—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000125	0.00109	CbGpPWpGaD
Hexobarbital—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000122	0.00107	CbGpPWpGaD
Hexobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00012	0.00105	CbGpPWpGaD
Hexobarbital—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000118	0.00103	CbGpPWpGaD
Hexobarbital—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000114	0.000995	CbGpPWpGaD
Hexobarbital—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000113	0.000991	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000111	0.000977	CbGpPWpGaD
Hexobarbital—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000111	0.00097	CbGpPWpGaD
Hexobarbital—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.000966	CbGpPWpGaD
Hexobarbital—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00011	0.00096	CbGpPWpGaD
Hexobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000108	0.000943	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000107	0.000937	CbGpPWpGaD
Hexobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000106	0.000931	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.000909	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.000909	CbGpPWpGaD
Hexobarbital—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.000909	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000103	0.000902	CbGpPWpGaD
Hexobarbital—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000102	0.000896	CbGpPWpGaD
Hexobarbital—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000101	0.000886	CbGpPWpGaD
Hexobarbital—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.95e-05	0.000872	CbGpPWpGaD
Hexobarbital—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.83e-05	0.000862	CbGpPWpGaD
Hexobarbital—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.81e-05	0.00086	CbGpPWpGaD
Hexobarbital—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	9.7e-05	0.00085	CbGpPWpGaD
Hexobarbital—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.69e-05	0.000849	CbGpPWpGaD
Hexobarbital—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	9.36e-05	0.00082	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.36e-05	0.00082	CbGpPWpGaD
Hexobarbital—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	9.34e-05	0.000819	CbGpPWpGaD
Hexobarbital—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.23e-05	0.000809	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	9.11e-05	0.000798	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	9.1e-05	0.000798	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	9.09e-05	0.000796	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	9.05e-05	0.000793	CbGpPWpGaD
Hexobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.91e-05	0.000781	CbGpPWpGaD
Hexobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.79e-05	0.00077	CbGpPWpGaD
Hexobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.73e-05	0.000765	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.72e-05	0.000764	CbGpPWpGaD
Hexobarbital—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.48e-05	0.000743	CbGpPWpGaD
Hexobarbital—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.39e-05	0.000735	CbGpPWpGaD
Hexobarbital—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.28e-05	0.000725	CbGpPWpGaD
Hexobarbital—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.27e-05	0.000725	CbGpPWpGaD
Hexobarbital—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.16e-05	0.000715	CbGpPWpGaD
Hexobarbital—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.04e-05	0.000705	CbGpPWpGaD
Hexobarbital—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.01e-05	0.000702	CbGpPWpGaD
Hexobarbital—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.96e-05	0.000697	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.76e-05	0.00068	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.68e-05	0.000673	CbGpPWpGaD
Hexobarbital—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	7.6e-05	0.000666	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.59e-05	0.000665	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.38e-05	0.000647	CbGpPWpGaD
Hexobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.22e-05	0.000633	CbGpPWpGaD
Hexobarbital—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	7.09e-05	0.000621	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7e-05	0.000613	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.92e-05	0.000606	CbGpPWpGaD
Hexobarbital—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.9e-05	0.000604	CbGpPWpGaD
Hexobarbital—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.8e-05	0.000596	CbGpPWpGaD
Hexobarbital—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.8e-05	0.000596	CbGpPWpGaD
Hexobarbital—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.51e-05	0.000571	CbGpPWpGaD
Hexobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.47e-05	0.000567	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	6.47e-05	0.000567	CbGpPWpGaD
Hexobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.39e-05	0.00056	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.38e-05	0.000559	CbGpPWpGaD
Hexobarbital—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.34e-05	0.000555	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.32e-05	0.000554	CbGpPWpGaD
Hexobarbital—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.29e-05	0.000551	CbGpPWpGaD
Hexobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.26e-05	0.000549	CbGpPWpGaD
Hexobarbital—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.25e-05	0.000548	CbGpPWpGaD
Hexobarbital—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.01e-05	0.000526	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.98e-05	0.000524	CbGpPWpGaD
Hexobarbital—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.93e-05	0.000519	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.91e-05	0.000518	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.82e-05	0.00051	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.74e-05	0.000503	CbGpPWpGaD
Hexobarbital—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.74e-05	0.000503	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	5.62e-05	0.000493	CbGpPWpGaD
Hexobarbital—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	5.52e-05	0.000483	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	5.4e-05	0.000473	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.4e-05	0.000473	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.32e-05	0.000466	CbGpPWpGaD
Hexobarbital—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.25e-05	0.00046	CbGpPWpGaD
Hexobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.25e-05	0.00046	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.16e-05	0.000453	CbGpPWpGaD
Hexobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.1e-05	0.000447	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.1e-05	0.000447	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.92e-05	0.000431	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.89e-05	0.000428	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.86e-05	0.000426	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.85e-05	0.000425	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	4.83e-05	0.000424	CbGpPWpGaD
Hexobarbital—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.82e-05	0.000423	CbGpPWpGaD
Hexobarbital—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.78e-05	0.000419	CbGpPWpGaD
Hexobarbital—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.64e-05	0.000406	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.62e-05	0.000405	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.61e-05	0.000404	CbGpPWpGaD
Hexobarbital—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.57e-05	0.000401	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.57e-05	0.0004	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.56e-05	0.0004	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.53e-05	0.000397	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.46e-05	0.000391	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.46e-05	0.000391	CbGpPWpGaD
Hexobarbital—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.45e-05	0.00039	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.45e-05	0.00039	CbGpPWpGaD
Hexobarbital—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.4e-05	0.000385	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.37e-05	0.000383	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.37e-05	0.000383	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.37e-05	0.000383	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.28e-05	0.000375	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.25e-05	0.000372	CbGpPWpGaD
Hexobarbital—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.23e-05	0.00037	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.2e-05	0.000368	CbGpPWpGaD
Hexobarbital—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.17e-05	0.000365	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	4.17e-05	0.000365	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.16e-05	0.000365	CbGpPWpGaD
Hexobarbital—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.16e-05	0.000365	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.15e-05	0.000363	CbGpPWpGaD
Hexobarbital—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.09e-05	0.000358	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.92e-05	0.000343	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.87e-05	0.00034	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.84e-05	0.000336	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.81e-05	0.000334	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.78e-05	0.000332	CbGpPWpGaD
Hexobarbital—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.76e-05	0.000329	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.73e-05	0.000327	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.73e-05	0.000327	CbGpPWpGaD
Hexobarbital—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.61e-05	0.000316	CbGpPWpGaD
Hexobarbital—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.56e-05	0.000312	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.4e-05	0.000298	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.2e-05	0.000281	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.2e-05	0.00028	CbGpPWpGaD
Hexobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.16e-05	0.000277	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.16e-05	0.000277	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	3.11e-05	0.000273	CbGpPWpGaD
Hexobarbital—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.1e-05	0.000272	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.09e-05	0.000271	CbGpPWpGaD
Hexobarbital—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.06e-05	0.000268	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.94e-05	0.000258	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.91e-05	0.000255	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.9e-05	0.000254	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.9e-05	0.000254	CbGpPWpGaD
Hexobarbital—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.79e-05	0.000244	CbGpPWpGaD
Hexobarbital—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.75e-05	0.000241	CbGpPWpGaD
Hexobarbital—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.72e-05	0.000238	CbGpPWpGaD
Hexobarbital—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.67e-05	0.000234	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.66e-05	0.000233	CbGpPWpGaD
Hexobarbital—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.63e-05	0.00023	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.47e-05	0.000216	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.45e-05	0.000215	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.42e-05	0.000212	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.4e-05	0.000211	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.28e-05	0.0002	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.25e-05	0.000197	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.25e-05	0.000197	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.24e-05	0.000197	CbGpPWpGaD
Hexobarbital—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.24e-05	0.000196	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.23e-05	0.000196	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.23e-05	0.000196	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.19e-05	0.000192	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.1e-05	0.000184	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.07e-05	0.000182	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.05e-05	0.00018	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.04e-05	0.000179	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.92e-05	0.000169	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.89e-05	0.000166	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.87e-05	0.000164	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.78e-05	0.000156	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.74e-05	0.000153	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.7e-05	0.000149	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.68e-05	0.000147	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.62e-05	0.000142	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.58e-05	0.000138	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.56e-05	0.000136	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.53e-05	0.000134	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.49e-05	0.00013	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.45e-05	0.000127	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.44e-05	0.000127	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.41e-05	0.000124	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.39e-05	0.000122	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.37e-05	0.00012	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.34e-05	0.000118	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.31e-05	0.000115	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.3e-05	0.000114	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.21e-05	0.000106	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.2e-05	0.000105	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.18e-05	0.000104	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.18e-05	0.000104	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.18e-05	0.000103	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.16e-05	0.000102	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.1e-05	9.67e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.09e-05	9.56e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.08e-05	9.5e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.08e-05	9.46e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.03e-05	9e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.02e-05	8.96e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.01e-05	8.86e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.95e-06	8.72e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.43e-06	8.26e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	9.35e-06	8.19e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.23e-06	8.09e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.1e-06	7.97e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.97e-06	7.86e-05	CbGpPWpGaD
Hexobarbital—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.94e-06	7.83e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.36e-06	7.33e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.3e-06	7.27e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.18e-06	7.17e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.93e-06	6.95e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.89e-06	6.92e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.8e-06	6.84e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.62e-06	6.68e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.23e-06	6.33e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.12e-06	6.24e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.09e-06	6.21e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.99e-06	6.13e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	6.98e-06	6.12e-05	CbGpPWpGaD
Hexobarbital—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.68e-06	5.85e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.56e-06	5.75e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.52e-06	5.71e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.18e-06	5.41e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.47e-06	4.8e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.4e-06	4.73e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.39e-06	4.72e-05	CbGpPWpGaD
Hexobarbital—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.15e-06	4.52e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.03e-06	4.41e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.91e-06	4.31e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.77e-06	4.18e-05	CbGpPWpGaD
Hexobarbital—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.7e-06	4.12e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.2e-06	3.68e-05	CbGpPWpGaD
Hexobarbital—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.02e-06	3.52e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.24e-06	2.84e-05	CbGpPWpGaD
Hexobarbital—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.1e-06	2.72e-05	CbGpPWpGaD
